544312 — Hamps Bio Balance Sheet
0.000.00%
- IN₹187.31m
- IN₹197.76m
- IN₹64.75m
Annual balance sheet for Hamps Bio, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.15 | 7.63 | 6.2 | 4.16 | 12.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9.51 | 7.33 | 6.91 | 7.6 | 11.1 |
Total Other Current Assets | |||||
Total Current Assets | 15.7 | 15.8 | 13.3 | 12.3 | 24.4 |
Net Property, Plant And Equipment | 26.1 | 30.2 | 21.5 | 26.1 | 25.6 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 42.2 | 46.4 | 36.4 | 39.6 | 51.5 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14.9 | 21.6 | 18 | 20.7 | 14 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 35.8 | 37.2 | 26.4 | 26 | 17.7 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 6.42 | 9.18 | 10.1 | 13.6 | 33.7 |
Total Liabilities & Shareholders' Equity | 42.2 | 46.4 | 36.4 | 39.6 | 51.5 |
Total Common Shares Outstanding |